Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suzanne R Hill

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Bulletin of the World Health Organization|March 31, 2012
Putting the priorities first: medicines for maternal and child healthSuzanne R Hill
BMC Medicine|February 3, 2012
Cost-effectiveness analysis for cliniciansSuzanne R Hill
Pharmacoeconomics|September 25, 2014
NICE, social values, and balancing objectivity and equitySuzanne R Hill, Leslie G Olson
Trends in Pharmacological Sciences|December 3, 2014
Fair and reasonable judgments of cost-effectiveness of medicinesLeslie G Olson, Suzanne R Hill
Bulletin of the World Health Organization|November 21, 2007
Setting standards for essential children's medicinesSuzanne R Hill, Andy Gray, Martin Weber
Pharmacoeconomics|December 23, 2017
Value-Based Pricing: L'Enfant Terrible?Sarah Garner, Andrew Rintoul, Suzanne R Hill
Bulletin of the World Health Organization|December 21, 2016
Clarifying WHO's position on the FRAX® tool for fracture predictionNathan Ford, Susan L Norris, Suzanne R Hill
JAMA Network Open|January 16, 2019
Comparison of Sales Income and Research and Development Costs for FDA-Approved Cancer Drugs Sold by Originator Drug CompaniesKiu Tay-Teo, André Ilbawi, Suzanne R Hill
JAMA|November 24, 2005
Drug prices and value for money: the Australian Pharmaceutical Benefits SchemeDavid A Henry, Suzanne R Hill, Anthony Harris
Bulletin of the World Health Organization|July 1, 2009
A comparison of two methods for measuring anti-hypertensive drug use: concordance of use with South African standard treatment guidelinesThamizhanban Pillay, Anthony J Smith, Suzanne R Hill
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Bulletin of the World Health Organization|March 31, 2012
Putting the priorities first: medicines for maternal and child healthSuzanne R Hill
BMC Medicine|February 3, 2012
Cost-effectiveness analysis for cliniciansSuzanne R Hill
Pharmacoeconomics|September 25, 2014
NICE, social values, and balancing objectivity and equitySuzanne R Hill, Leslie G Olson
Trends in Pharmacological Sciences|December 3, 2014
Fair and reasonable judgments of cost-effectiveness of medicinesLeslie G Olson, Suzanne R Hill
Bulletin of the World Health Organization|November 21, 2007
Setting standards for essential children's medicinesSuzanne R Hill, Andy Gray, Martin Weber
Pharmacoeconomics|December 23, 2017
Value-Based Pricing: L'Enfant Terrible?Sarah Garner, Andrew Rintoul, Suzanne R Hill
Bulletin of the World Health Organization|December 21, 2016
Clarifying WHO's position on the FRAX® tool for fracture predictionNathan Ford, Susan L Norris, Suzanne R Hill
JAMA Network Open|January 16, 2019
Comparison of Sales Income and Research and Development Costs for FDA-Approved Cancer Drugs Sold by Originator Drug CompaniesKiu Tay-Teo, André Ilbawi, Suzanne R Hill
JAMA|November 24, 2005
Drug prices and value for money: the Australian Pharmaceutical Benefits SchemeDavid A Henry, Suzanne R Hill, Anthony Harris
Bulletin of the World Health Organization|July 1, 2009
A comparison of two methods for measuring anti-hypertensive drug use: concordance of use with South African standard treatment guidelinesThamizhanban Pillay, Anthony J Smith, Suzanne R Hill
Pageof 3